Pay in 4 interest-free payments of $7.50 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Placebo-Controlled
is a potent and selective mTOR inhibitor
21)16-7-6-15(28(24
TUG-891 displays similar signaling properties to the LCFA α-linolenic acid at human FFA4
Acalabrutinib - CAS# 1420477-60-6 size:10mg solid Placebo-ControlledAcalabrutinib, also known as ACP 196, CAS No. 1420477 60 6, is an orally available inhibitor of Brutons tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, ACP 196 inhibits the activity of BTK and prevents the activation of the B cell antigen receptor (BCR) signaling pathway. This prevents both B cell activation and BTK mediated activation of downstream survival pathways. This leads to an inhibition of the growth of
US$ 15950.00
US$ 39.99
US$ 180.00